Insulin Dependent Diabetes Mellitus


Why cell therapy?

Health and Wellness begins at the cellular level and it is estimated that over 5-million patients have been treated with some form of cell therapy since the 1930s. Cell therapy is widely used in many countries within the field of regenerative medicine, as a first resort not the last.

How well does cell therapy respond to Diabetes?

Cell therapy is a better treatment for type 1 diabetes and a powerful tool for controlling the advanced complications of type 2 diabetes with no serious risk or adverse reactions. As the clinical experience of the past four decades has shown, Progenitor Cell treatment can stop the relentless progress of the complications of Diabetes Mellitus once they start. This implies that the transplanted cells of all organs and tissues involved in carbohydrate metabolism produce - directly or indirectly - the missing (endocrine or paracrine) hormones. After the diagnosis of a diabetic complication is established, Stem Cell treatment given early can increase the success rate of the treatment. Statistics prove the effectiveness with various complications of insulin dependent diabetes mellitus (IDDM). The success rate for diabetic nephropathy is approximately 60% and higher among early stage. For diabetic retinopathy the success rate is 65% and higher for early stage. In those with diabetic lower extremity arterial disease the success rate is 65%. Painful severe diabetic Polyneuropathy has a success rate as high as 98%.

Is cell therapy a new treatment?

Not at all... for over 70-years cell therapy has been used safely and effectively in Europe, Russia, Republic of China, New Zealand, Middle East, Pacific Rim, Central and South America, Mexico and more recently the United States, under select clinical trials.

What type of Cell therapy is Used?

ProGenaCell and its affiliated physicians offer advanced stem cell treatments for Diabetes and the often debilitating associated symptoms. Our physicians use a combination of two stem cell therapies that have proven effective for tissue restoration and integrated care for the incurable and obstinate diseases.

The stem cells ProGenaCell physicians use are pluripotent, non-specialized cells able to differentiate (turn) into other cell types. Cord blood stem cells have the highest potential for differentiation and proliferation and are not rejected by the patient's body.

Cord Blood cells have been used for over 40 years with no adverse side effects. The NIH (National Institute of Health) has stated that they have seen no cases of cancer or other health threats arising from stem-cell therapy.

ProGenaCell is one of the very few companies who also works with doctors and scientists in Germany who have perfected the use and administration of Growth Factors - with a 35-year track record.

Xenocells (Growth Factors) begin from the selection of specific organ cells from a fetal animal bred specifically for this purpose. Sheep, known to be strong and hardy animals are considered the best donor animals, with strong immunity against diseases. Moreover, sheep proteins are compatible with the human body without triggering any immune defense reactions for Diabetes patients.

Our physicians have treated numerous patients in various states of Diabetes, greatly extending valuable years and improving the quality of life. Cell therapy restores function to injured, diseased, and debilitated tissues and organs.

Cord Blood cell therapy and Xeno cell therapy (Growth Factors) are administered free of any type of surgery. All of these cells are processed using the very highest standards and state-of-the-art technology available.

Insulin Dependent Diabetes Mellitus

  • To Hear from a ProGenaCell Representative

    Fill out an Information Request Form Today! How can we help?